Latest news
RYTM Maintained by JP Morgan -- Price Target Raised to $146 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:17:20 GMTHow Investors May Respond To Rhythm Pharmaceuticals (RYTM) Q2 Results And Early RM-718 Obesity Data - simplywall.stsimplywall.st · Thu, 06 Aug 2026 20:48:45 GMTCitigroup Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - MarketBeatMarketBeat · Wed, 05 Aug 2026 19:51:22 GMTMorgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $150 - MoomooMoomoo · Wed, 05 Aug 2026 16:00:26 GMTCCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $154 - MoomooMoomoo · Wed, 05 Aug 2026 15:56:53 GMTRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $160.00 - MarketBeatMarketBeat · Wed, 05 Aug 2026 15:47:10 GMTRBC Adjusts Price Target on Rhythm Pharmaceuticals to $155 From $141, Maintains Outperform Rating - MoomooMoomoo · Wed, 05 Aug 2026 13:54:06 GMTRhythm Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RYTM) 2026-08-05 - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 13:49:32 GMT